4.6 Article

The clinical implications and molecular features of intrahepatic cholangiocarcinoma with perineural invasion

期刊

HEPATOLOGY INTERNATIONAL
卷 17, 期 1, 页码 63-76

出版社

SPRINGER
DOI: 10.1007/s12072-022-10445-1

关键词

Perineural invasion; Intrahepatic cholangiocarcinoma; Sympathetic nerve; KRAS; Pathology feature; Metastasis prone niche; Adjuvant therapy; Overall survival; Relapse-free survival; Bioinformatics

向作者/读者索取更多资源

This study reveals the genomic features and the immune suppressive metastasis-prone niche of intrahepatic cholangiocarcinoma (ICC) with perineural invasion (PNI). Patients with PNI have a poor prognosis after surgery but show a good response to adjuvant chemotherapy.
Background Perineural invasion (PNI) is associated with metastasis in malignancies, including intrahepatic cholangiocarcinoma (ICC), and is correlated with poor prognosis. Methods The study included three large cohorts: ZS-ICC and TMA cohorts from our team, MSK cohort from a public database, and a small cohort named cohort 4. Prognostic implications of PNI were investigated in MSK cohort and TMA cohort. PNI-related genomic and transcriptomic profiles were analyzed in MSK and ZS-ICC cohorts. GO, KEGG, and ssGSEA analyses were performed. Immunohistochemistry was used to investigate the relationship between PNI and markers of neurons, hydrolases, and immune cells. The efficacy of adjuvant therapy in ICC patients with PNI was also assessed. Results A total of 30.6% and 20.7% ICC patients had PM in MSK and TMA cohorts respectively. Patients with PNI presented with malignant phenotypes such as high CA19-9, the large bile duct type, lymph node invasion, and shortened overall survival (OS) and relapse-free survival (RFS). Nerves involved in PNI positively express tyrosine hydroxylase (TH), a marker of sympathetic nerves. Patients with PNI showed high mutation frequency of KRAS and an immune suppressive metastasis prone niche of decreased NK cell, increased neutrophil, and elevated PD-L1, CD80, and CD86 expression. Patients with PNI had an extended OS after adjuvant therapy with TEGIO, GEMOX, or capecitabine. Conclusion Our study deciphered the genomic features and the immune suppressive metastasis-prone niche in ICC with PNI. Patients with PNI showed a poor prognosis after surgery but a good response to adjuvant chemotherapy. [GRAPHICS] .

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据